Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

KRM 1671

Known as: 25-deacetyl-KRM-1648, KRM-1671, Rifamycin VIII, 25-O-deacetyl-1',4-didehydro-1-deoxy-1,4-dihydro-3'-hydroxy-5'-(4-(2-methylpropyl)-1-piperazinyl)-1-oxo- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Rifalazil is a rifamycin derivative from Kaneka that is in phase II clinical trials for the treatment of Mycobacterium… Expand
Is this relevant?